- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07227077
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of this study is to test a theory-based, micro-randomized trial to determine the optimal state to deliver a message to increase physical activity by determining the probability older cancer survivors will be physically active in the one hour following a messaging prompt. The secondary, exploratory objective is to determine the probability older cancer survivors will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.
Eligibility criteria is deliberately incomplete to preserve the scientific integrity of the study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kelly Clohesey Clinical Research Coordinator, MOT
- Phone Number: 4149554099
- Email: kclohesey@mcw.edu
Study Contact Backup
- Name: Whitney Morelli, PhD
- Email: wmorelli@mcw.edu
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Recruiting
- Froedtert Hospital
-
Contact:
- Kelly Clohesey Clinical Research Coordinator, MOT
- Phone Number: 414-801-6710
- Email: kclohesey@mcw.edu
-
Principal Investigator:
- Whitney Morelli, Assistant Professor, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age greater than or equal to 65 years.
- Patients with a history of bladder, breast, cervical, colorectal, endometrial, lung, and prostate cancer diagnosis and treatment.
- Fluent in spoken and written English.
- Patient has access to smartphone
- Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion Criteria:
- Patient has metastatic disease.
- Patient has cancer recurrence.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Micro-randomized trial study arm
In this one-armed, 4-week trial, participants will receive prompts to report their pain symptoms 4 times throughout the day.
Participants may receive up to 4 reminders to move messages throughout the day to promote participants to engage in physical activity.
The receipt of messages is randomized each day.
Participants will wear a research-grade activity monitor throughout the duration of their participation in the intervention to measure physical activity behaviors.
|
This physical activity promotion intervention is a micro-randomized trial designed to determine the most effective time to send a message to promote physical activity among cancer survivors who experience chronic pain symptoms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ActiGraph accelerometer measured physical activity behaviors (sedentary, light, moderate, vigorous intensity).
Time Frame: 4 weeks
|
Physical activity will be measured using an ActiGraph accelerometer.
Data will be aggregated into physical activity estimations (sedentary, light, moderate, vigorous, steps, etc.) using standard methods.
Outcome of interest will be probability older cancer survivors are physically active in the 30 minutes following the receipt of a messaging prompt to promote physical activity.
|
4 weeks
|
|
11-point box scale to assess pain on a scale of 0 (no pain) to 10 (worst possible pain).
Time Frame: 4 weeks
|
Pain state will be assessed by response to the pain rating measured by the 11-Point Box Scale in the study app.
Participants will receive a smart phone prompt to rate their pain 4 times per day.
Outcome of interest will be probability older cancer survivors experience a pain episode in the 24 hours following the receipt of a messaging prompt to increase physical activity.
|
4 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Neurologic Manifestations
- Genital Neoplasms, Male
- Urogenital Neoplasms
- Neoplasms by Site
- Neoplasms
- Genital Diseases, Male
- Prostatic Diseases
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Intestinal Diseases
- Respiratory Tract Diseases
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Uterine Diseases
- Genital Diseases, Female
- Lung Diseases
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Colonic Diseases
- Genital Neoplasms, Female
- Skin Diseases
- Breast Diseases
- Urologic Neoplasms
- Uterine Cervical Diseases
- Uterine Neoplasms
- Urinary Bladder Diseases
- Pathological Conditions, Signs and Symptoms
- Behavior
- Skin and Connective Tissue Diseases
- Signs and Symptoms
- Pain
- Prostatic Neoplasms
- Lung Neoplasms
- Colorectal Neoplasms
- Breast Neoplasms
- Uterine Cervical Neoplasms
- Urinary Bladder Neoplasms
- Endometrial Neoplasms
- Motor Activity
Other Study ID Numbers
- PRO00055140
- K01CA255414 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Cancer
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Tata Memorial HospitalMahidol University; Juntendo University; Gunma University; Chiang Mai University...RecruitingStage IIA Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO 2018 | Stage IIIB Cervical Cancer FIGO 2018 | Stage IVA Cervical Cancer FIGO 2018 | Stage IB Cervical Cancer FIGO 2018India, Japan, Thailand
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingCervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Stage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCervical Cancer | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer
-
Qi ZhouNot yet recruitingCervical Cancer Recurrent | Cervical Cancer Metastatic
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingCervical Cancer Recurrent | Cervical Cancer Metastatic
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingCervical Large Cell Neuroendocrine Carcinoma | Cervical Neuroendocrine Carcinoma | Cervical Small Cell Carcinoma | Cervical Undifferentiated Carcinoma | Stage I Cervical Cancer AJCC v8 | Stage IA Cervical Cancer AJCC v8 | Stage IA1 Cervical Cancer AJCC v8 | Stage IA2 Cervical Cancer AJCC v8 | Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IA1 Cervical Cancer | Stage IA2 Cervical Cancer | Stage IB1 Cervical Cancer | Stage IB2 Cervical Cancer | Stage IB3 Cervical CancerUnited States
Clinical Trials on Physical Activity Promotion Intervention
-
University of NebraskaNational Institute of Nursing Research (NINR)CompletedPhysical ActivityUnited States
-
University of California, San DiegoCompletedBreast CancerUnited States
-
The Children's Hospital of Zhejiang University...Not yet recruitingCongenital Heart Disease | Physical InactivityChina
-
Polytechnic University of SantarémSPRINT Sport Physical Activity and Health Research & Innovation CenterRecruitingPregnant Women Participating in a Supervised Multicomponent Exercise InterventionPortugal
-
Northumbria UniversityNewcastle-upon-Tyne Hospitals NHS TrustCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
UKK InstituteFinnish Institute of Occupational Health; Finnish Sports Confederation; Päijät-Hämeen... and other collaboratorsCompletedPhysical Activity | Sedentary Behavior | Work AbilityFinland
-
KU LeuvenVLIR-UOS; Kyambogo University; Our Lady of Africa Mbuya Catholic ParishCompleted
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedArthritis | Joint Diseases | Osteoarthritis | Osteoarthritis, Knee | Anterior Cruciate Ligament Injuries | Knee Injuries | Exercise | Cartilage, ArticularUnited States
-
University of PennsylvaniaRobert Wood Johnson FoundationCompleted
-
VASCage GmbHMedical University Innsbruck; Tirol Kiniken GmbH; Management Center InnsbruckCompletedLife Style, Healthy | Life StyleAustria